types of hypertension
DESCRIPTION
Hypertension is defined as systolic blood pressure (SBP) of 140 mmHg or greater, diastolic blood pressure (DBP) of 90 mmHg or greater, or taking antihypertensive medication. VI JNC, 1997. Types of hypertension. Essential hypertension 90% No underlying cause Secondary hypertension - PowerPoint PPT PresentationTRANSCRIPT
Hypertension is defined as systolic blood
pressure (SBP) of 140 mmHg or greater,
diastolic blood pressure (DBP) of
90 mmHg or greater, or taking
antihypertensive medication.VI JNC, 1997
Types of hypertension
Essential hypertension 90%
No underlying cause
Secondary hypertension Underlying cause
Causes of Secondary Hypertension
Renal Parenchymal Vascular Others
Endocrine Neurogenic Miscellaneous Unknown
Hypertension: Predisposing factors Age > 60 years Sex (men and postmenopausal women) Family history of cardiovascular disease Smoking High cholesterol diet Co-existing disorders such as diabetes,
obesity and hyperlipidaemia High intake of alcohol Sedentary life style
1999 WHO-ISH Guidelines :Definitions and Classifications of BP Levels
SBP DBPCategory* (mm Hg) (mm Hg)Optimal < 120 < 80Normal < 130 < 85High-normal 130-139 85-89Grade 1 hypertension (mild) 140-159 90-99 Borderline subgroup 140-149 90-94Grade 2 hypertension (moderate) 160-179 100-109Grade 3 hypertension (severe) > 180 > 110ISH > 140 < 90 Borderline subgroup 140-149 < 90
WHO-ISH Guidelines Subcommittee J Hypertens 1999; 17:151
1999 WHO-ISH Guidelines:Stratification of risk to Quantify Prognosis
Degree of hypertension (mm Hg)Risk factors and Grade 1-mild Grade 2-moderate Grade3-severedisease history (SBP 140-159 (SBP 160-179 (SBP > 180
or DBP 90-99) or DBP 100-109) or DBP > 110)I No other risk Low risk Med risk High risk
factorsII 1-2 risk factors Med risk Med risk Very high riskIII > 3 risk factors or High risk high risk Very high risk
target organ diseaseor diabetes
IV Associated Very high risk Very high risk Very high riskClinical conditions
WHO-ISH Guidelines Subcommittee J Hypertens 1999;17:151
Diseases Attributable to Hypertension
HYPERTENSION
Gangrene of the Lower Extremities
Heart Failure
Left Ventricular Hypertrophy Myocardial
InfarctionHypertensive
EncephalopathyAortic
Aneurym
Blindness
Chronic Kidney Failure
Stroke Preeclampsia/Eclampsia
Cerebral Hemorrhage
Coronary Heart Disease
Adapted from Dustan HP et al. Arch Intern Med. 1996; 156: 1926-1935
1999 WHO-ISH Guidelines: Desirable BP Treatment Goals
Optimal or normal BP (< 130/85 mm Hg) for Young patientsMiddle-age patientsDiabetic patients
High-normal BP (< 140/90 mm Hg) desirable for elderly patients
Aggressive BP lowering may be necessary in patients with nephropathy, chronic renal failure, particularly if proteinuria is
< 1 g/d - 130/80 mm Hg> 1 g/d - 125/75 mm Hg
Significant benefits from intensive BP reductionin diabetic patients
24.4
18.6
11.9
0
5
10
15
20
25
30
< 90 mm Hg < 85 mm Hg < 80 mm Hg (targetDBP)
Major CV events / 100 patient-yr
Lancet 1998, 351, 1755
Relative risks of specific types of clinical complicationsrelated to tight and less tight BP Control
Patients with Absolute risk aggregate (events/1000 and points patients-yr)
Tight Less tight Less RR forcontrol control Tight tight tight control
Clinical end point (n=758) (n=390) control control p (95% Cl)Any diabetes-related 259 170 50.9 67.4 0.0046 0.76 (0.62-0.92)end pointDeaths related to 82 62 13.7 20.3 0.019 0.68 (0.49-0.94)diabetesAll cause mortality 134 83 22.4 27.2 0.17 0.82 (0.63-1.08)Myocardial infarction 107 69 18.6 23.5 0.13 0.79 (0.59-1.07)Stroke 38 34 6.5 11.6 0.013 0.56 (0.35-0.89)Peripheral vascular 8 8 1.4 2.7 0.17 0.51 (0.19-1.37)diseaseMicrovascular disease 68 54 12.0 19.2 0.0092 063 (0.44-0.89)
Ref : UK Prospective Diabetes Study Group BMJ 1998; 317:703
Life style modifications
Lose weight, if overweight Limit alcohol intake Increase physical activity Reduce salt intake Stop smoking Limit intake of foods rich in fats
and cholesterol
Factors affecting choice of antihypertensive drug
The cardiovascular risk profile of the patient
Coexisting disorders
Target organ damage
Interactions with other drugs used for concomitant conditions
Tolerability of the drug
Cost of the drug
Drug therapy for hypertension
Class of drug Example Initiating dose Usualmaintenance dose
Diuretics Hydrochlorothiazide 12.5 mg o.d. 12.5-25 mg o.d.
-blockers Atenolol 25-50 mg o.d. 50-100 mg o.d.
Calcium Amlodipine 2.5-5 mg o.d. 5-10 mg o.d.channelblockers
-blockers Doxazosin 1 mg o.d. 1-8 mg o.d.
ACE- inhibitors Lisinopril 2.5-5 mg o.d. 5-20 mg o.d.
Angiotensin-II Losartan 25-50 mg o.d. 50-100 mg o.d.receptor blockers
Diuretics
Example: Hydrochlorothiazide Act by decreasing blood volume and cardiac output Decrease peripheral resistance during chronic therapy Drugs of choice in elderly hypertensivesDrawbacks Hypokalaemia Hyponatraemia Hyperlipidaemia Hyperuricaemia (hence contraindicated in gout) Hyperglycaemia (hence not safe in diabetes) Not safe in renal and hepatic insufficiency
Beta blockers
Example: Atenolol Block 1 receptors on the heart Block 2 receptors on kidney and inhibit release of renin Decrease rate and force of contraction and thus reduce
cardiac output Drugs of choice in patients with co-existent coronary
heart diseaseDrawbacks Adverse effects: lethargy, impotency, bradycardia Not safe in patients with co-existing asthma and diabetes Have an adverse effect on the lipid profile
Calcium channel blockers
Example: Amlodipine Block entry of calcium through calcium channels Cause vasodilation and reduce peripheral
resistance Drugs of choice in elderly hypertensives and
those with co-existing asthma Neutral effect on glucose and lipid levels
Drawbacks Adverse effects: Flushing, headache, Pedal
edema
ACE inhibitors
Example: Lisinopril, Enalapril Inhibit ACE and formation of
angiotensin II and block its effects Drugs of choice in co-existent diabetes
mellitus
Drawbacks Adverse effect: dry cough, hypotension,
angioedema
Angiotensin II receptor blockers
Example: Losartan Block the angiotensin II receptor
and inhibit effects of angiotensin II Drugs of choice in patients with
co-existing diabetes mellitus
Drawbacks Adverse effect: dry cough,
hypotension, angioedema
Alpha blockers
Example: Doxazosin Block -1 receptors and cause vasodilation Reduce peripheral resistance and venous
return Exert beneficial effects on lipids and insulin
sensitivity Drugs of choice in patients with co-existing
hyperlipidaemia, diabetes mellitus and BPH
Drawbacks Adverse effects: Postural hypotension
Antihypertensive therapy:Side-effects and Contraindications
Class of drugs Main side-effects Contraindications/Special Precautions
Diuretics Electrolyte imbalance, Hypersensitivity, Anuria(e.g. Hydrochloro- total and LDL cholesterol thiazide) levels, HDL cholesterol
levels, glucose levels, uric acid levels
-blockers Impotence, Bradycardia, Hypersensitivity, (e.g. Atenolol) Fatigue Bradycardia, Conduction
disturbances, Diabetes,Asthma, Severe cardiacfailure
Class of drug Main side-effects Contraindications/ SpecialPrecautions
Calcium channel blockers Pedal edema, Headache Non-dihydropyridine(e.g. Amlodipine, CCBs (e.g diltiazem)– Diltiazem) Hypersensitivity,
Bradycardia, Conductiondisturbances, Congestive heartfailure, Left ventriculardysfunction.Dihydropyridine CCBs– Hypersensitivity
-blockers Postural hypotension Hypersensitivity(e.g. Doxazosin)
ACE-inhibitors Cough, Hypertension, Hypersensitivity, Pregnancy,(e.g. Lisinopril) Angioneurotic edema Bilateral renal artery stenosis
Angiotensin-II receptor Headache, Dizziness Hypersensitivity, Pregnancy,blockers (e.g. Losartan) Bilateral renal artery stenosis
Antihypertensive therapy: Side-effects and Contraindications (Contd.)
Choosing the right antihypertensive
Condition Preferred drugs Other drugs Drugs to be that can be used avoidedAsthma Calcium channel -blockers/Angiotensin-II -blockers
blockers receptor blockers/Diuretics/ACE-inhibitors
Diabetes -blockers/ACE Calcium channel blockers Diuretics/mellitus inhibitors/ -blockers
Angiotensin-IIreceptor blockers
High cholesterol -blockers ACE inhibitors/ Angiotensin-II -blockers/levels receptor blockers/ Calcium Diuretics
channel blockersElderly patients Calcium channel -blockers/ACE- (above 60 years)blockers/Diuretics inhibitors/Angiotensin-II
receptor blockers/- blockersBPH -blockers -blockers/ ACE inhibitors/
Angiotensin-II receptorblockers/ Diuretics/Calcium channel blockers
Limitations on use of antihypertensives in patientswith coexisting disorders
Coexisting Diuretic -blocker ACE All CCB -blockerDisorder inhibitorantagonist
Diabetes Caution/x Caution/x
Dyslipidaemia x x
CHD
Heart failure /Caution Caution
Asthma/COPD x /Caution
Peripheral Caution Caution Caution vasculardisease
Renal artery x x stenosis
Effect of various antihypertensives on coexisting disorders
Total LDL- HDL- Serum Glucose Insulincholesterol cholesterol cholesterol triglycerides tolerance sensitivity
Diuretic
-blockers - - -
ACEinhibitors - - - -
Allantagonists - - - -
CCBs - - - - - -
-blockers
Combination therapy for hypertension – Recommended by JNC-VI guidelines and 1999 WHO-ISH guidelines
With any single drug, not more than 25–50% of hypertensives achieve adequate blood pressure control
J Hum. Hypertens 1995; 9:S33–S36
For patients not responding adequatelyto low doses of monotherapy
Increase the dose of drug. This, however, may lead to
increased side effects
Substitute with another drug from a different class
Add a second drug from a different class
(Combination therapy)
Add second drug from different class (Combination therapy)
If inadequate response obtained
Advantages of fixed-dosecombination therapy
Better blood pressure control
Lesser incidence of individual
drug’s side-effects
Neutralisation of side-effects
Increased patient compliance
Lesser cost of therapy
Fixed-dose combinations as recommended byJNC-VI (1997) guidelines and 1999 WHO-ISH guidelines
Calcium channel blocker and -blocker(e.g. Amlodipine and Atenolol)
Calcium channel blocker and ACE-inhibitor (e.g. Amlodipine and Lisinopril)
ACE-inhibitor and Diuretic (e.g. Lisinopril and Hydrochlorothiazide)
-blocker and Diuretic (e.g. Atenolol and Hydrochlorothiazide)
0
50
100
150
200
Systolic Diastolic
Basal Week 4
Blo
od P
ress
ure
(mm
Hg)
Reduces BP effectively
Safe and well tolerated Adverse events were reported in 7.9% of patients Common side effects included edema, fatigue and headache
Indian Practitioner 1997; 50: 683-688.
0
10
20
30
40
50
60
70
80
90
% re
spon
ders
175.4+19.4 143.8
+ 13.2106.8+ 10.5 88.2
+ 7.6
80.5%
Efficacy and Tolerability of a fixed-dose combination of amlodipine andatenolol (Amlopres-AT) in Indian Hypertensives (n=369)
Efficacy and Tolerability of combined amlodipine andlisinopril (Amlopres-L) in Indian hypertensives (n=330)
0
50
100
150
200
Systolic Diastolic
Basal Week 4
Blo
od P
ress
ure
(mm
Hg)
Reduces BP effectively
Safe and well tolerated Adverse events were reported in 9.7% of patients Side effects commonly reported included cough and edema Only 1.76% of patients withdrew from the study.
Indian Practitioner 1998; 51: 441-447.
0
10
20
30
40
50
60
70
80
90
% re
spon
ders
175.4+19.4
143.8+ 13.2 106.8
+ 10.5 88.2+ 7.6
77.65
Drugs in special conditionsCondition
Pregnancy
Coronary heart disease
Congestive heart failure
Preferred Drugs
Nifedipine, labetalol, hydralazine, beta-blockers, methyldopa, prazosin
Beta-blockers, ACE inhibitors, Calcium channel blockers
ACE inhibitors,beta-blockers
1999 WHO-ISH guidelines
Summary Hypertension is a major cause of morbidity
and mortality, and needs to be treated
It is an extremely common condition; however it is still underdiagnosed and undertreated
Hypertension is not controlled with monotherapy in at least 50% of patients; in these patients combination therapy is required